CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Since 2024, she has been a researcher at the Aging Biology Laboratory of the Institute of Biology at the University of Campinas (UNICAMP), where she studies the role of microRNAs and lipodystrophy in Alzheimers disease.She completed a postdoctoral fellowship (20182024) at the Neuroscience Laboratory of the Institute of Chemistry at the University of São Paulo (USP), investigating the involvement of the purinergic system in animal behaviors related to Alzheimers disease and depression.She holds Master (2013) and Ph.D. (2017) degrees in Sciences from the Department of Pharmacology at the Ribeirão Preto Medical School University of São Paulo. She also earned a Ph.D. in Health Sciences from Aarhus University (Denmark) through a double degree agreement.In her Masters research, she studied the role of the nitrergic system in mood and anxiety disorders, while her Ph.D. focused on the participation of the purinergic signaling in stress-induced behaviors and the effect of antidepressant drugs.She holds a Bachelor's degree in Pharmaceutical Sciences from the Federal University of Alfenas (2010). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Early onset Alzheimer's disease (AD) affects individuals under 65 years old, which are often in a very productive phase and possess several family responsibilities leading to profound negative impacts in the patients and their families' life. Despite extensive research showing that genetic mutations in the amyloid precursor protein (APP) and presenilin 1 (PS1) genes are associated with ea…
Alzheimer's Disease (AD) is a disabling psychiatric disorder that affects approximately 18 million people worldwide. The causes of this disorder are not well elucidated given their complexity, and the symptoms generally progress from memory loss to language and motor impairment, often including depression. Despite its great impact on the patient, family and society, the therapies availabl…
Depression is a heterogeneous syndrome with complex and variable symptoms. Therefore, this disorder requires a careful diagnosis and appropriate treatment. However, antidepressants available for clinical use are ineffective in about 45% of patients with depression. Thus, the search for new pharmacological targets for the depression treatment is necessary. The purinergic receptors are wide…
Alzheimer's Disease (AD) and major depression (MD) are highly comorbid conditions which have no effective treatment recently available to prevent their chronification. This situation may be ascribed to the translational gap between animal-based models used in preclinical studies and patients as well as under-explored pathological mechanisms underlying AD and MD. Aiming to address these is…
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |